And in the MRI and MR spectroscopy here, the prostate tumor activity is shown in red you can see it diminishing after a year.

In prostate cancer, the cells of these prostate glands mutate into cancer cells.

Prostate cancer. I don't need to give you many statistics about prostate cancer.

Screening for prostate cancer, too, requires a blood test the prostate specific antigen (PSA) test.

Benign tumor.

Tumor, was it?

The tumor in your leg is not consistent with a benign tumor.

like breast, prostate and colon cancer.

Does this virus cause prostate cancer?

We showed a few months ago we published the first study showing you can actually stop or reverse the progression of prostate cancer by making changes in diet and lifestyle, and 70 percent regression in the tumor growth, or inhibition of the tumor growth, compared to only nine percent in the control group.

We showed a few months ago we published the first study showing you can actually stop or reverse the progression of prostate cancer by making changes in diet and lifestyle, and 70 percent regression in the tumor growth, or inhibition of the tumor growth, compared to only nine percent in the control group.

Infection or inflammation of the prostate (prostatitis) may increase the chance for prostate cancer while another study shows infection may help prevent prostate cancer by increasing blood to the area.

Prostate cancer also experiences significantly less media coverage than other, equally prevalent cancers, with a study by Prostate Coalition showing 2.6 breast cancer stories for each one covering cancer of the prostate.

So here's a tumor.

A brain tumor. Nice!

Prostate cancer is a case in point.

It's used to test for prostate cancer, but there are all sorts of reasons why your prostate might be enlarged.

Is it a brain tumor?

I want to do it for prostate cancer.

Men with prostate cancer whose PSA level increased by more than 2.0 ng per milliliter during the year before the diagnosis of prostate cancer have a higher risk of death from prostate cancer despite undergoing radical prostatectomy.

In the setting of prostate cancer, up to 60 percent of men after prostate cancer surgery may have urinary incontinence and erectile disfunction.

In the United States in 2005, there were an estimated 230,000 new cases of prostate cancer and 30,000 deaths due to prostate cancer.

In the setting of prostate cancer, up to 60 percent of men after prostate cancer surgery may have urinary incontinence and erectile disfunction.

In cancer research experiments, tumor cells are sometimes injected into an experimental animal to establish a tumor.

The prostate is a zinc accumulating, citrate producing organ.

In 1998, screening for the prostate specific antigen began.

We fund prostate cancer foundations now in 13 countries.

In 2007, the Foundation launched campaigns in Canada (funds raised go to the Prostate Cancer Research Foundation of Canada), Spain (FEFOC), the United Kingdom (Prostate Cancer UK), and the United States (the Prostate Cancer Foundation and the Livestrong Foundation).

Flocks was the first to experiment with antigens in the prostate and 10 years later Albin reported the presence of precipitation antigens in the prostate.

Mandela was successfully treated for prostate cancer in July 2001.

The most commonly castrated men are advanced prostate cancer patients.

So now, that guy is getting screened for prostate cancer.

It's in the liver, in the breast, in the prostate.

The USPSTF recently issued an even sharper warning about the prostate specific antigen test for prostate cancer, after concluding that the test s harms outweigh its benefits.

We think the entire tumor is out.

Can you tell where the tumor is?

In this case, a one centimeter tumor.

So the first two applications are breast cancer and prostate cancer.

Prostate cancer. I don't need to give you many statistics about prostate cancer. Most of you already know it third leading cause of cancer deaths in the U.S.

And that's when we call it a tumor.

Maybe even find a tumor, in some cases.

It's not brain tumor, but I have headache.

Tumor cells can travel through the blood vessels.

So the data that we collect for prostate cancer or for Alzheimer's trials goes into silos where it can only be used for prostate cancer or for Alzheimer's research.

A November 2009 study in mice shows that activating the tumor suppressor p53 with a new drug, nutlin 3, may slow tumor growth.